Ambu A/S Market Cap ($2.88 Billion)
Market Cap & Net Worth: Ambu A/S (AMBU-B)
Ambu A/S market cap. Ambu A/S (CO:AMBU-B) has a market capitalization of $2.88 Billion (Dkr18.41 Billion) as of November 1, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #4849 globally and #33 in its home market, demonstrating a 2.01% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ambu A/S's stock price Dkr81.20 by its total outstanding shares 226726039 (226.73 Million). Also see AMBU-B cash flow metrics for how efficiently the company converts equity into cash flow.
Ambu A/S Market Cap History (2015–2026)
Ambu A/S market cap history from 2015 to 2026. Data shows growth from $1.46 Billion to $2.88 Billion (6.92% CAGR). Check Ambu A/S stock quote for real-time trading data and today's change.
Ambu A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ambu A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Ambu A/S growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.52x
Ambu A/S's market cap is 0.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.13x
Ambu A/S's market cap is 5.13 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.99 Billion | $2.08 Billion | $250.00 Million | 0.95x | 7.94x |
| 2017 | $3.91 Billion | $2.35 Billion | $301.00 Million | 1.66x | 12.98x |
| 2018 | $5.52 Billion | $2.61 Billion | $337.00 Million | 2.12x | 16.38x |
| 2019 | $3.95 Billion | $2.82 Billion | $317.00 Million | 1.40x | 12.46x |
| 2020 | $9.32 Billion | $3.57 Billion | $241.00 Million | 2.61x | 38.67x |
| 2021 | $6.14 Billion | $4.01 Billion | $247.00 Million | 1.53x | 24.85x |
| 2022 | $3.16 Billion | $4.44 Billion | $93.00 Million | 0.71x | 33.95x |
| 2023 | $3.73 Billion | $4.78 Billion | $168.00 Million | 0.78x | 22.21x |
| 2024 | $3.69 Billion | $5.39 Billion | $235.00 Million | 0.68x | 15.70x |
| 2025 | $3.12 Billion | $6.04 Billion | $609.00 Million | 0.52x | 5.13x |
Competitor Companies of AMBU-B by Market Capitalization
Companies near Ambu A/S in the global market cap rankings as of November 1, 2026. Also see total assets of Ambu A/S for a full breakdown of the balance sheet.
Key companies related to Ambu A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Ambu A/S (2015–2026)
Market capitalization of Ambu A/S from 2015 to today. Between 2015 and today, Ambu A/S's market cap moved from $1.46 Billion to $ 2.88 Billion, with a yearly change of 6.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr2.88 Billion | -7.73% |
| 2025 | Dkr3.12 Billion | -15.38% |
| 2024 | Dkr3.69 Billion | -1.14% |
| 2023 | Dkr3.73 Billion | +18.20% |
| 2022 | Dkr3.16 Billion | -48.55% |
| 2021 | Dkr6.14 Billion | -34.16% |
| 2020 | Dkr9.32 Billion | +135.96% |
| 2019 | Dkr3.95 Billion | -28.42% |
| 2018 | Dkr5.52 Billion | +41.19% |
| 2017 | Dkr3.91 Billion | +96.82% |
| 2016 | Dkr1.99 Billion | +36.07% |
| 2015 | Dkr1.46 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Ambu A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.88 Billion USD |
| MoneyControl | $2.88 Billion USD |
| MarketWatch | $2.88 Billion USD |
| marketcap.company | $2.88 Billion USD |
| Reuters | $2.88 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more